A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 3, 2015, Pages 480-488

  Vargo, John A ^a   Ferris, Robert L ^a,b   Ohr, James ^b   Clump, David A ^a   Davis, Kara S ^b   Duvvuri, Umamaheswar ^b   Kim, Seungwon ^b   Johnson, Jonas T ^b   Bauman, Julie E ^b   Gibson, Michael K ^b   Branstetter, Barton F ^c   Heron, Dwight E ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; TOXICITY;

COMMON TERMINOLOGY CRITERIA; CONCURRENT CETUXIMAB; METHODS AND MATERIALS; NATIONAL CANCER INSTITUTE; OVERALL TREATMENT TIME; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY;

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BLEEDING DISORDER; BODY RASH; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYBERKNIFE; DISTANT METASTASIS FREE SURVIVAL; DOSIMETRY; DRUG EFFICACY; DRUG ERUPTION; DYSPHAGIA; ESOPHAGUS STENOSIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INJECTION SITE DESQUAMATION; KIDNEY FUNCTION; LARYNGECTOMY; LIVER FUNCTION; LOADING DRUG DOSE; LOCAL RECURRENCE FREE SURVIVAL; MALE; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHARYNX DISEASE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION INJURY; STEREOTACTIC BODY RADIATION THERAPY; TRACHEOESOPHAGEAL FISTULA; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PROCEDURES; RADIATION DOSE; RADIOSURGERY; RETREATMENT; SALVAGE THERAPY; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETREATMENT; SALVAGE THERAPY; TIME FACTORS;

EID: 84923253758     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.11.023     Document Type: Article

References (34)

1. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
2. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
3. C. Fakhry, Q. Zhang, and P.F. Nguyen-Tan Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma [e-pub ahead of print] J Clin Oncol 32 2014 3365 3373
4. J.S. Cooper, T.F. Pajak, and P. Rubin Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience Int J Radiat Oncol Biol Phys 17 1989 449 456
5. A.P. Coatesworth, A. Tsikoudas, and K. MacLennan The cause of death in patients with head and neck squamous cell carcinoma J Laryngol Otol 116 2002 269 271
6. M.W. McDonald, J. Lawson, and M.K. Garg ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation Int J Radiat Oncol Biol Phys 80 2011 1292 1298
7. M. Clavel, J.B. Vermorken, and F. Cognetti Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck: A phase III study of the EORTC Head and Neck Cancer Cooperative Group Ann Oncol 5 1994 521 526
8. A. Argiris, Y. Li, and A. Forastiere Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck Cancer 101 2004 2222 2229
9. S.A. Spencer, J. Harris, and R.H. Wheeler Final report of RTOG 9610, a multi-institutional trial of re-irradiation and chemotherapy for unresectable recurrence squamous cell carcinoma of the head and neck Head Neck 30 2008 281 288
10. C.J. Langer, J. Harris, and E.M. Horwitz Phase II study of low-dose paclitaxel and cisplatin in combination with split course concomitant twice daily reirradiation in Recurrent squamous cell carcinoma of the head and neck: Results of RT oncology group protocol 9911 J Clin Oncol 25 2007 4800 4805
11. E.P. Sulman, D.L. Schwartz, and T.T. Le IMRT reirradiation of head and neck cancer - Disease control and morbidity outcomes Int J Radiat Oncol Biol Phys 73 2009 399 409
12. J.K. Salama, E.E. Vokes, and S.J. Chmura Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head and neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 64 2006 382 391
13. D.E. Heron, R.L. Ferris, and M. Karmouzis Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: Results of a phase I dose-escalation trial Int J Radiat Oncol Biol Phys 75 2009 1493 1500
14. J.B. Vermorken, R. Mesia, and F. Rivera Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
15. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of head and neck N Engl J Med 354 2006 567 578
16. D.E. Heron, J.C. Rwigema, and M.K. Gibson Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study Am J Clin Oncol 34 2011 165 172
17. K. Wang, D.E. Heron, and D.A. Clump Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation Radiother Oncol 106 2013 90 95
18. J.C. Rwigema, D.E. Heron, and R.L. Ferris The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy Am J Clin Oncol 34 2011 372 379
19. E.A. Weymuller, R. Alsarraf, and B. Yueh Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R) Arch Otolaryngol Head Neck Surg 127 2001 489 493
20. S. Warren, and O. Gates Multiple primary malignant tumors. A survey of the literature and a statistical study Am J Cancer 16 1932 1358 1414
21. E.F. Lartigau, E. Tresch, and J. Thariat Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer Radiother Oncol 109 2013 281 285
22. J.A. Vargo, D.E. Heron, and R.L. Ferris Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer Radiother Oncol 104 2012 91 95
23. F. Zwicker, F. Roeder, and C. Thieke IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer Strahlenther Onkol 187 2011 32 38
24. P. Balermpas, C. Keller, and M. Hambek Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: Feasibility and first efficacy results Int J Radiat Oncol Biol Phys 83 2012 e377 383
25. F. Duprez, I. Mandani, and K. Bonte High-dose reirradiation with intensity-modulated radiotherapy for recurrent head and neck cancer: Disease control, survival and toxicity Radiother Oncol 111 2014 388 392
26. K.W. Roh, J.S. Jang, and M.S. Kim Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer Int J Radiat Oncol Biol Phys 74 2009 1348 1355
27. M. Cengiz, G. Ozyigit, and G. Yazici Salvage reirradiation with stereotactic body radiotherapy for locally recurrent head and neck tumors Int J Radiat Oncol Biol Phys 81 2011 104 109
28. B. Comet, A. Kramar, and M. Faivre-Pierret Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head and neck cancer: A feasibility study Int J Radiat Oncol Biol Phys 84 2012 203 209
29. G. Yazici, T.Y. Snli, and M. Cengiz A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiation for recurrent head and neck cancers Radiat Oncol 8 2013 242
30. J.A. Vargo, D.E. Heron, and R.L. Ferris Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: Implications of treatment duration and tumor volume Head Neck 36 2014 1349 1355
31. H. Yamazaki, M. Ogita, and N. Kodani Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated reirradiation of head and neck cancer using CyberKnife: A multi-institutional study Radiother Oncol 107 2013 305 309
32. A. Popovtzer, I. Gluck, and D.B. Chepeha The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: Implications for defining the targets Int J Radiat Oncol Biol Phys 74 2009 1342 1347
33. K.E. Rusthoven, S.J. Feigenberg, and D. Raben Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head and neck cancer Int J Radiat Oncol Biol Phys 15 2010 1020 1025
34. T.Y. Seiwert, T. Darga, and D. Haraf A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation Ann Oncol 24 2013 769 776